Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank62
3Y CAGR+24.3%
5Y CAGR-6.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+24.3%/yr
vs -31.6%/yr prior
5Y CAGR
-6.0%/yr
Recent acceleration
Acceleration
+55.9pp
Accelerating
Percentile
P62
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.09 | +63.0% |
| 2024 | 0.06 | +8.3% |
| 2023 | 0.05 | +8.9% |
| 2022 | 0.05 | -6.1% |
| 2021 | 0.05 | -59.4% |
| 2020 | 0.12 | -20.6% |
| 2019 | 0.15 | -27.7% |
| 2018 | 0.21 | -79.4% |
| 2017 | 1.04 | +55.0% |
| 2016 | 0.67 | - |